A global survey of 817 bladder cancer patients and 802 urologists reveals that standard treatments like bladder removal surgery and BCG therapy significantly harm patients' physical, emotional, and mental health. Over 90% of patients report negative impacts, including missed social moments and feelings of humiliation managing symptoms. Both patients and doctors express a strong desire for more innovative treatments that better address quality of life and emotional support. The findings highlight the need for shared decision-making and advancing care options to reduce treatment burdens and improve patient well-being.
A 66-year-old retiree in Pennsylvania aimed to generate $55,000 annually from a $1.1 million portfolio but lost $2,400 in tax savings because her IRA automatically reinvested dividends shortly after she sold shares at a loss. This triggered the IRS w...
Nanobiotix and Johnson & Johnson presented early Phase 2 trial data for JNJ-1900 (NBTXR3), a novel nanoradioenhancer, in stage 3 inoperable non-small cell lung cancer (NSCLC). The treatment, combined with chemoradiotherapy and durvalumab, showed an o...
The healthcare sector, particularly healthcare equipment, is currently undervalued compared to historical averages. The iShares U.S. Pharmaceuticals ETF (IHE) has notably outperformed the broader healthcare ETF XLV by 27% over the past year, driven l...
